Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) | MicrobiomeTrials
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-10-02Est. Completion: 2026-10-02
Enrollment target: 50 participants
Locations
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain